Clinical Trial Update: 36-month Special Drug Use Surveillance on Frequency of Bone Fractures With Sodium Risedronate 75 mg Tablets

View source ↗

Summary

A completed clinical trial update assessing the frequency of bone fractures with Sodium Risedronate 75 mg tablets in osteoporosis patients, with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Sodium Risedronate 75 mg tablets (risedronate)

Snippet

Sponsor: Takeda | Conditions: Osteoporosis | Status: COMPLETED | Results posted: 2019-07-17